Cerenis Therapeutics
HealthcareBiotech & Pharma
HQ: Toulouse, France
Investors: 1
HDL-mimetic therapies for lipid disorders
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
HDL-mimetic therapies for lipid disorders
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |